Revealing the Synergistic Anticancer Efficacy of Curcumin and Iota‐Carrageenan‐Stabilized Silver Nanoparticles Derived From Solieria robusta.

In this study, a red seaweed (Solieria robusta) containing ι‐carrageenan (Carr) was used for nanoparticles (NPs) synthesis using silver (Ag) ions. Initially, the ι‐Carr was extracted from S. robusta using the alkali method. The Carr extracted was fractionated into 3 fractions and > 14 kDa fraction showing high yield with maximum sulfate content characterized using Fourier transform infrared (FT‐IR) as ι‐Carr was used for AgNPs synthesis. The synthesized CarrAgNPs were again used for curcumin (Cur) encapsulation. The cytotoxicity of Carr, Cur, CarrAgNPs, and CurCarrAgNPs was evaluated using HeLa cell lines by MTT assay. The CarrAgNPs and CurCarrAgNPs were characterized using UV‐visible spectroscopy, as well as FT‐IR and XRD analysis. The UV‐visible spectrum confirms the CarrAgNPs showing characteristic SPR bands recorded between 344 and 490 nm with broad peak at 430 nm. The shape of the NPs is spherical, arranged in order of seven per chain. The XRD and FT‐IR characteristics confirm the orthorhombic crystal structure of these NPs. Remarkably, Cur‐loaded CarrAgNPs demonstrate potent anticancer properties by maximum reduction of HeLa cell viability after 24 h at 200 μg/mL in pH 7.4 in an MTT assay medium. A significant increase in the cancer cell viability was recorded at high concentrations of CurCarrAgNPs, confirming its less diffusion and dissolution properties and bioavailability due to lipophilic Cur encapsulation, whereas cytotoxicity was increased proportionately by increasing concentrations of Cur, Carr, and CarrAgNPs that confirm a direct relation with size, dissolution, and bioavailability recorded on the basis of cell death in 24 h of introduction at pH 7.4. The cytotoxicity results suggest the potential of Cur, Carr, CarrAgNPs, and CurCarrAgNPs for drug delivery in selective biomedical product developments. This study highlights the versatility and effectiveness of CurCarrAgNPs in cancer therapy by enhancing the efficacy of therapeutic interventions and targeted drug delivery. [ABSTRACT FROM AUTHOR]